Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-label, Evaluation of a 13C-urea Breath Test for the Detection of Urease-producing Bacteria in Patients Diagnosed With Pneumonia in the Emergency Department
Conditions
Interventions
13C-urea breath test
Locations
1
United States
Henry Ford Health System
Detroit, Michigan, United States
Start Date
May 1, 2017
Primary Completion Date
June 4, 2020
Completion Date
June 4, 2020
Last Updated
July 14, 2025
NCT07428759
NCT06238297
NCT07406334
NCT05976581
NCT06602557
NCT06113432
Lead Sponsor
University of New Mexico
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions